Eye Study Beaver Dam is categorized under Infectious Disease Specialists in Madison, WI .
Eye Study Beaver Dam was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Ronald Klein, Executive Director at the company’s single location by writing to 610 Walnut St, Madison, Wisconsin WI 53726 or by phoning (920) 885-6800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Eye Study Beaver Dam |
Contact Person: | Ronald Klein, Executive Director |
Address: | 610 Walnut St, Madison, Wisconsin 53726 |
Phone Number: | (920) 885-6800 |
Website Address: | bdeyestudy.org |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Infectious Disease Specialists |
SIC Code: | 8011 |
NAICS Code: | 6214930 |
Share This Business: |
Eye Study Beaver Dam was started in 0 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Ronald Klein, Executive Director for inquiries that concern Eye Study Beaver Dam by calling the company number (920) 885-6800, as your correspondence is most welcome. Additionally, the physical location of the single location of Eye Study Beaver Dam can be found at the coordinates 43.07743,-89.42515 as well as the street address 610 Walnut St in Madison, Wisconsin 53726.
For its online presence, you may visit Eye Study Beaver Dam’s website at bdeyestudy.org and engage with its social media outlets through on Twitter and on Facebook.